Martin is the CEO of Biosyntia, a biotech company based in Copenhagen, Denmark. Biosyntia develops fermentation processes to deliver better, bio-based ingredients for the nutritional and personal care markets. Biosyntia has a unique bacterial toolbox to deliver high-yielding processes for molecules such as vitamins, essential co-factors, nutraceuticals and flavors.
Martin has previously worked with commercializing new biotech platforms in Novozymes. He has also worked for Boston Consulting Group in both Europe & Australia on projects involving M&A due diligences, strategy development and operational effectiveness. Martin has former experience from roles such as Head of Sales within Hilti Denmark and First Lieutenant in the Danish Army. He holds a M.Sc. degree in Finance & Strategic Management from Copenhagen Business School and Australian Graduate School of Management.